Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
A Novel Interpretable Transfer Learning Framework for Analyzing High-Dimensional Longitudinal Ophthalmic Data
Author Affiliations & Notes
  • TingFang Lee
    Department of Ophthalmology, NYU Grossman School of Medicine, New York, New York, United States
    Division of Biostatistics, Department of Population Health, NYU Grossman School of Medicine, New York, New York, United States
  • Gadi Wollstein
    Department of Ophthalmology, NYU Grossman School of Medicine, New York, New York, United States
    Department of Biomedical Engineering, NYU Tandon School of Engineering, New York, New York, United States
  • Ronald Zambrano
    Department of Ophthalmology, NYU Grossman School of Medicine, New York, New York, United States
  • Andrew Wronka
    Medical Center Information Technology, NYU Grossman School of Medicine, New York, New York, United States
  • Lei Zheng
    Wills Eye Hospital, Philadelphia, Pennsylvania, United States
  • Joel S Schuman
    Wills Eye Hospital, Philadelphia, Pennsylvania, United States
    Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, Pennsylvania, United States
  • Jiyuan Hu
    Division of Biostatistics, Department of Population Health, NYU Grossman School of Medicine, New York, New York, United States
  • Footnotes
    Commercial Relationships   TingFang Lee None; Gadi Wollstein None; Ronald Zambrano None; Andrew Wronka None; Lei Zheng None; Joel Schuman AEYE Health, Alcon Laboratories, Inc., Boehringer Ingelheim, Carl Zeiss Meditec, Ocugenix, Ocular Therapeutix, Opticient, Regeneron Pharmaceuticals, Inc., SLACK, Code E (Employment), BrightFocus Foundation, National Eye Institute, Perfuse, Inc., Code F (Financial Support), AEYE Health, Ocugenix, Ocular Therapeutix, Opticient, Code I (Personal Financial Interest), Carl Zeiss Meditec, New York Univ Sch of Med, Ocugenix, SLACK, Tufts Univ School of Medicine, University of Pittsburgh Medical Center, Code P (Patent); Jiyuan Hu None
  • Footnotes
    Support  P30EY013079, R01-EY013178, an unrestricted grant from Research to Prevent Blindness
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3733. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      TingFang Lee, Gadi Wollstein, Ronald Zambrano, Andrew Wronka, Lei Zheng, Joel S Schuman, Jiyuan Hu; A Novel Interpretable Transfer Learning Framework for Analyzing High-Dimensional Longitudinal Ophthalmic Data. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3733.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Various transfer learning (TL) approaches have been developed in deep learning model schemes to address data inequality and discrepancies between datasets and domains. While TL has recently been introduced to enhance health equity in healthcare, particularly ophthalmology and vision health, persistent challenges include adequately modeling complex dependency structures such as longitudinal and multi-modal data, along with ensuring the interpretability. This study aims to develop a novel TL machine learning framework for analyzing high-dimensional longitudinal ophthalmic data, prioritizing model interpretability and accounting for temporal and inter-eye correlations.

Methods : The TL framework adopts a generalized linear mixed-effects regression model to investigate the association of longitudinally measured covariates, efficiently handling complex data dependencies such as repeated measurements. A two-step transfer algorithm is implemented to leverage information from source domain for enhancing the prediction task in the target domain. L1-regularization techniques are used to address high dimensionality. We conducted a simulation study with a target sample size of 500, and source sample size ranging from 200 to 1200 with 5 temporal repeated measurements for each sample. We compared the proposed TL method with Naïve lasso regression model fitted using only the target domain, evaluating model prediction accuracy and parameter estimation through mean square errors (MSE) and L2-estimators of estimated coefficients, respectively.

Results : The simulation study demonstrates that the TL method outperforms the naïve lasso method, evidenced by lower MSE and L2-estimators. Furthermore, L2-estimators of the proposed TL method exhibit a clear trend of decreasing as the sample size of the source domain increases, indicating the benefit of borrowing information from the source domain (Figure 1).

Conclusions : The proposed TL framework enhances model prediction accuracy compared with the naïve method. The selected features from the TL framework, along with corresponding estimated coefficients, offer a comprehensive interpretation of each feature’s contribution to the outcome of interest. This TL framework provides an efficient and flexible solution to address sample size constraints in the target domain, mitigate data imbalance issues, and handle complex data structures in clinical research.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×